Security key
03836J102
Aprea Therapeutics, Inc. - Common Stock, par value $0.001 per share (APRE)
CUSIP: 03836J102
Q4 2022 13F Holders as of 31 Dec 2022
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 1,587,074
- Total 13F value
- $520,280
- Share change
- -44,778
- Put/Call ratio
- 2.5%
- SEC-reported price per share
- $0.33
- Number of holders
- 23
- Value change
- -$37,678
- Number of buys
- 12
- Number of sells
- 10
- Shares outstanding
- 228,836,687
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2022
Institutions
23
Top holders
10
APRE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2023
Previous quarter: Q3 2022
Aprea Therapeutics, Inc. SEC filings
Aprea Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03836J102
Recent filing periods:
Ownership snapshot
Top reported holders of APRE - Aprea Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MORGAN STANLEY
Disclosed value leader
MORGAN STANLEY
Comparable rows
15/15
Latest evidence
30 Sep 2022
13F
Lead comparable stake: 0.14%
Showing 1-6 of 15 holder rows.
Quick read
MORGAN STANLEY leads the comparable SEC ownership view at 0.14%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MORGAN STANLEY's linked filing trail.
Comparable ownership
Top 5
MORGAN STANLEY
0.14%
VANGUARD GROUP INC
0.14%
RENAISSANCE TECHNOLOGIES LLC
0.12%
BlackRock Finance, Inc.
0.08%
GEODE CAPITAL MANAGEMENT, LLC
0.07%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
Company
|
0.14%
|
$202,000
311,591 shares
|
— | 30 Sep 2022 |
| VANGUARD GROUP INC |
13F
Company
|
0.14%
|
$201,000
309,598 shares
|
— | 30 Sep 2022 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.12%
|
$184,000
282,541 shares
|
— | 30 Sep 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
0.08%
|
$121,000
185,741 shares
|
— | 30 Sep 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.07%
|
$97,000
150,142 shares
|
— | 30 Sep 2022 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
0.05%
|
$79,000
121,333 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
23
Shares
1,587,074
Rows available
23
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
23
Q4 2022 holders
23
Holder diff
0
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend